Table of Contents
| << Previous Issue | Jun 2024 (Vol: 2024, Issue: 6) | Next Issue >> |
- Section: Licensing
-
AbbVie Signs US$1.7 B Pact with FutureGen for IBD Drug
- Section: Mergers & Acquisitions
-
J&J Gains Rights to Numab Therapeutics’ Atopic Dermatitis Drug for US$1.25 B
-
Merck & Co. to Acquire EyeBio for US$3 B to Expand Ophthalmology Pipeline
- Section: Research & Development
-
Lilly Collaborates with QurAlis to Develop ALS Therapies



RSS